Ankylosing Spondylitis

This is a long-term condition that causes inflammation and pain in the joints connecting your spine. It often affects young men and can lead to stiffness and fusion of the spine over time.

Condition

What people with Ankylosing Spondylitis report

Every report comes from a Lived member, sent anonymously.

Have you tried Humira (Adalimumab) for Ankylosing Spondylitis?

NameHow it went

About Ankylosing Spondylitis

What It Is

Ankylosing spondylitis (AS) is a long-term inflammatory arthritis that mainly affects the spine and the sacroiliac joints, where the base of the spine meets the pelvis. Its typical sign is pain and stiffness in the lower back, buttocks or hips that is worse during the night or after sitting for a long time. Because that pattern can look like an ordinary sore back, AS is often mistaken for a mechanical back problem at first. Symptoms usually begin in young adulthood, typically before age 45. Over years, ongoing inflammation can lead the body to form new bone between the vertebrae, gradually stiffening or fusing parts of the spine and, in some people, causing a stooped posture. AS can also inflame the places where tendons and ligaments attach to bone, other joints, and the joints between the ribs and spine, which can make a deep breath feel restricted. Outside the joints, it can affect the eyes, bowel and skin. AS belongs to a broader group called axial spondyloarthritis. The name ankylosing spondylitis is used when joint damage shows on an X-ray. People with the same kind of symptoms but no X-ray changes yet have non-radiographic axial spondyloarthritis, which is treated in much the same way.

Causes & Risk Factors

The cause of AS is not known, but genes and environment both appear to play a part. The strongest known genetic link is HLA-B27 (human leukocyte antigen B27), an inherited marker carried on the surface of immune cells. Most people of European ancestry who have AS carry it, yet only about 5 to 8 percent of people who carry HLA-B27 ever develop the disease. The marker raises risk; it does not decide the outcome. AS is more common, and often more severe, in men, and having a relative with AS increases the chance of developing it. People with psoriasis or with an inflammatory bowel disease such as Crohn's disease or ulcerative colitis are also more likely to develop AS. Women are diagnosed later than men on average, partly because their symptoms are less often recognized as AS.

How It's Diagnosed

No single test diagnoses AS. A clinician pieces together the pattern of back pain, a physical exam, family history and related conditions such as psoriasis, bowel disease or past eye inflammation, and then uses blood tests and imaging to support or argue against the diagnosis. Blood tests usually check for HLA-B27 and for inflammation markers such as C-reactive protein (CRP). Each has limits. CRP is raised in only about half of people with axial spondyloarthritis, so a normal result does not rule it out. A positive HLA-B27 test is common in people who will never get AS, and a negative one does not exclude it, especially in groups where the marker is less common: only about half of Black Americans with AS carry it. Imaging focuses on the sacroiliac joints. An X-ray shows established damage such as erosions or fusion, but those changes typically take 5 to 10 years of disease to show clearly. Magnetic resonance imaging (MRI) can reveal active inflammation earlier. MRI is not perfect either: similar-looking changes appear in some healthy people, including many athletes and women who have recently given birth, so a scan is read alongside symptoms and other findings rather than on its own. Because early back pain is so common and nonspecific, the time from first symptoms to diagnosis is often 2 to 6 years.

Treatment Options

There is no cure for AS, but treatment can substantially ease pain and stiffness, help keep the spine flexible and let people stay active at work and at home. Most plans combine regular exercise with medicine. Exercise and physical therapy are a core part of treatment, not an add-on. Stretching, strengthening and posture work help maintain movement. Studies, though small, show improvement in pain, function and spinal mobility, and supervised group therapy tends to help more than exercising alone at home. Stopping smoking is also part of managing the disease. Nonsteroidal anti-inflammatory drugs (NSAIDs), such as naproxen or ibuprofen, are the first medicines tried, and in one study about a third of people improved significantly within four weeks. US guidelines favor taking them regularly while the disease is active. The trade-off is that long-term use can harm the stomach, kidneys and heart, so a history of ulcers, kidney disease or heart disease shapes how they are used. NSAIDs relieve symptoms; whether they slow spinal fusion is not proven. When the disease stays active after trying at least two NSAIDs, the next step is usually a biologic medicine, which blocks a specific signal the immune system uses to drive inflammation. Tumor necrosis factor (TNF) inhibitors, such as adalimumab (Humira) and etanercept (Enbrel), are usually tried first. Interleukin-17 (IL-17) inhibitors, such as secukinumab (Cosentyx) and ixekizumab (Taltz), are an alternative and are preferred over a second TNF inhibitor when the first one did not work at all. These are given by injection. Upadacitinib (Rinvoq), a tablet from a class called Janus kinase (JAK) inhibitors, is approved for adults whose AS did not respond to, or who could not tolerate, a TNF inhibitor; it has less long-term safety data and carries safety warnings drawn from studies in rheumatoid arthritis. Other conditions help steer the choice. TNF antibody medicines are preferred for people with recurring eye inflammation or inflammatory bowel disease, and IL-17 inhibitors for people with significant psoriasis. TNF inhibitors raise the risk of serious infections, including reactivation of tuberculosis (TB), so a TB test is done before starting. Long-term steroid pills are generally avoided. Traditional arthritis medicines such as sulfasalazine do not help spine symptoms, though sulfasalazine may be used for persistent swelling in other joints when a TNF inhibitor is not an option. Surgery may be needed when severe damage limits movement.

What to Expect

AS is a lifelong condition, and its course varies widely. Some people have symptoms that come and go, with long quiet periods; others have ongoing pain and stiffness. Fatigue is common. Over years, some people develop fusion that limits bending and turning. Treatment that controls inflammation helps people stay mobile and keep working, although whether medicines slow fusion over the long term is still being studied. Daily life usually centers on a regular exercise routine, attention to posture and medication that is reviewed at follow-up visits. Those visits track pain, stiffness, function and blood markers of inflammation. Routine repeat spine X-rays are not needed, but an MRI can help when it is unclear whether ongoing symptoms come from active inflammation. Once a biologic is working, stopping it often brings symptoms back, sometimes within weeks to months; in observational studies about 60 to 74 percent of people relapsed after stopping a TNF inhibitor. Any change is best planned with the prescriber rather than made alone. Sleep problems and low mood can add to pain and fatigue, and treating them is part of good care.

When to Seek Help

Arrange a medical evaluation for back or buttock pain that has lasted for months, started before age 45 and is worse at night or after sitting, especially if you also have psoriasis, inflammatory bowel disease, past eye inflammation or a relative with AS. If you already have AS, contact your care team when flares are no longer controlled, when a medicine causes troubling side effects, or when you develop an infection while taking a biologic. Sudden eye pain, sensitivity to light or blurred vision may be uveitis, an inflammation inside the eye that affects up to 40 percent of people with axial spondyloarthritis. Have your eyes examined the same day, because delayed treatment can permanently harm vision. A stiff or fused spine can break after even a minor fall or jolt, and the fracture is easy to miss because people with AS already live with back pain. Get emergency evaluation for new or worsening neck or back pain after any injury, and call 911 for numbness, tingling or weakness in the arms or legs after an injury.

Questions to Ask Your Doctor

  1. 1.Do my symptoms, blood tests and imaging point to AS, or could something else explain my back pain?
  2. 2.How will we measure whether the disease is active, and how often should I be seen?
  3. 3.What exercise or physical therapy program would help me most, and is a supervised program available to me?
  4. 4.If NSAIDs are not enough, how would we choose between a TNF inhibitor, an IL-17 inhibitor or another option given my other health conditions?
  5. 5.Am I at risk of bone thinning or spinal fracture, and should I have a bone density test?

Last reviewed • Oct 2026

Educational content, not medical advice.